Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies.
Inflammation contributes to growth failure associated with inflammatory bowel diseases. Anti-TNFα therapy induces sustained remission and short-term improvements in height velocity and/or height standard deviation score (H-SDS) patients with Crohn's disease. The purpose of this study was to eva...
Main Authors: | Sarah Bamberger, Christine Martinez Vinson, Damir Mohamed, Jérôme Viala, Jean-Claude Carel, Jean-Pierre Hugot, Dominique Simon |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5026336?pdf=render |
Similar Items
-
Effects of introduction of an inflammatory bowel disease nurse position on healthcare use
by: Christine Martinez-Vinson, et al.
Published: (2020-05-01) -
Long-term clinical and real-world experience with Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
by: Haruka Otake, et al.
Published: (2022-10-01) -
Prevalence of Yersinia Species in the Ileum of Crohn's Disease Patients and Controls
by: Guillaume Le Baut, et al.
Published: (2018-09-01) -
Long-term prognosis of Japanese patients with biologic-naïve Crohn’s disease treated with anti-tumor necrosis factor-α antibodies
by: Rintaro Moroi, et al.
Published: (2019-01-01) -
Network Modeling of Crohn's Disease Incidence.
by: Jean-Marc Victor, et al.
Published: (2016-01-01)